Your browser doesn't support javascript.
loading
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti, P; Caraffa, Al; Gallenga, C E; Ross, R; Kritas, S K; Frydas, I; Younes, A; Ronconi, G.
  • Conti P; Postgraduate Medical School, University of Chieti, 66013 Chieti, Italy.
  • Caraffa A; School of Pharmacy, University of Camerino, Camerino, Italy.
  • Gallenga CE; Molecular Medicine, Department of Morphology, Surgery, Experimental Medicine, University of Ferrara, Ferrara, Italy.
  • Ross R; University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104, USA.
  • Kritas SK; Department of Microbiology, University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Frydas I; School of Veterinary Medicine, University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Younes A; Centro Medico "Mai più Dolore", Pescara, Italy.
  • Ronconi G; Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00100 Roma, Italy.
J Biol Regul Homeost Agents ; 34(6): 1971-1975, 2020.
Article en En | MEDLINE | ID: mdl-33016027
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interleucina-1 / Síndrome de Liberación de Citoquinas / COVID-19 Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interleucina-1 / Síndrome de Liberación de Citoquinas / COVID-19 Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article